BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9331797)

  • 1. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region.
    Yoshinaga M; Miyata K; Fischetti VA
    Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal immunisation of mice with a streptococcal peptide-based vaccine.
    Relf W; Hayman W; Russell-Jones G; Good M
    Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788
    [No Abstract]   [Full Text] [Related]  

  • 3. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF
    Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF
    Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity evoked by synthetic peptides of streptococcal M proteins.
    Beachey EH
    Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological crossreactivity between the class I epitope of streptococcal M protein and myosin.
    Cunningham MW; Quinn A
    Adv Exp Med Biol; 1997; 418():887-92. PubMed ID: 9331792
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.
    Hoe NP; Kordari P; Cole R; Liu M; Palzkill T; Huang W; McLellan D; Adams GJ; Hu M; Vuopio-Varkila J; Cate TR; Pichichero ME; Edwards KM; Eskola J; Low DE; Musser JM
    J Infect Dis; 2000 Nov; 182(5):1425-36. PubMed ID: 11015234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.
    Pruksakorn S; Galbraith A; Houghten RA; Good MF
    J Immunol; 1992 Oct; 149(8):2729-35. PubMed ID: 1383324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.
    Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF
    Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of type-specific anti-streptococcal M-protein antibodies with biotinylated peptides in human sera.
    Kühnemund O; Schumacher F; Casaretto M; Holm SE; Lütticken R
    APMIS; 1998 Feb; 106(2):288-92. PubMed ID: 9531961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizontal transfer and mosaic-like emm gene structures in group A streptococci.
    Bessen DE; Hollingshead SK
    Dev Biol Stand; 1995; 85():169-73. PubMed ID: 8586170
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune response to pneumococcal proteins during experimental human carriage.
    McCool TL; Cate TR; Moy G; Weiser JN
    J Exp Med; 2002 Feb; 195(3):359-65. PubMed ID: 11828011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions.
    Fischetti VA; Bessen DE; Schneewind O; Hruby DE
    Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563
    [No Abstract]   [Full Text] [Related]  

  • 16. Conserved and variable regions in protein Arp, the IgA receptor of Streptococcus pyogenes.
    Hedén LO; Lindahl G
    J Gen Microbiol; 1993 Sep; 139(9):2067-74. PubMed ID: 8245833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
    Jones KF; Fischetti VA
    J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response.
    Schulze K; Medina E; Talay SR; Towers RJ; Chhatwal GS; Guzmán CA
    Infect Immun; 2001 Jan; 69(1):622-5. PubMed ID: 11119566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.
    Fluckiger U; Jones KF; Fischetti VA
    Infect Immun; 1998 Mar; 66(3):974-9. PubMed ID: 9488384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
    Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
    Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.